Reaktion #1519146
ord-2c87197585444fc8a864d8e4bfcdd314
Reaktionsgleichung
compound
trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine dihydrochloride
diisopropylethylamine
5-(chloromethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
→
expected product
trans-5-[(4-{2-[(3,5-Dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazin-1-yl)methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
Edukte
Reagenzien
Keine
Lösungsmittel
Reaktionsbedingungen
Detaillierte Bedingungen
See reaction.notes.procedure_details.
Aufarbeitung
- 1Sonstigeprepared
- 2Sonstigeevaporated to dryness
- 3SonstigeThe residue obtained
- 4Waschenwashed
- 5Sonstigedried
- 6Filtrationfiltered
- 7Sonstigeevaporated
- 8SonstigeThe oil obtained
- 9Sonstigeis purified by flash chromatography on silica
Vorschrift
After reconversion to the base, the compound obtained in Step C of Example 1 (2.14 mmol) is dissolved in 30 ml of dimethylformamide. There are added 0.75 ml (4.28 mmol) of diisopropylethylamine and 314 mg (2.35 mmol) of 5-(chloromethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one prepared according to the method described in Tetrahedron Letters, 2000, 41, 8661. The mixture is stirred for 12 hours at ambient temperature and then evaporated to dryness. The residue obtained is taken up in dichloromethane, washed, dried, filtered and evaporated. The oil obtained is purified by flash chromatography on silica to yield the expected product.